An interview with Prof. Jack Grzybowski, head of the Cardiomyopathy Unit at the National Institute of Cardiology.
What is the situation now for patients with transthyretin amyloidosis?
Patients with transthyretin amyloidosis of the heart have recently had the potential for effective treatment, but also the possibility of effective, non-invasive diagnostic imaging. The problems now are two. First: awareness of the disease is low, because the disease is also very rare. It is important to spread awareness of it. Th...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
